A: The Commission's independence rules apply to audits of financial statements required by SEC rules, except for those required by Rule 3-05 and 3-14 of Regulation S-X and Item 310(c) and (e) of Regulation S-B.
1 The Centers for Disease Control and Prevention (CDC) recommends 2 doses of quadrivalent meningococcal conjugate vaccine for adolescents 11 through 18 years of age.  The first dose should be given at 11 or 12 years of age, followed by a booster dose at age 16.
CDC recommends routine administration of a quadrivalent meningococcal conjugate vaccine MenACWY for all people aged 11â18 years. A single dose of vaccine should be administered at age 11 or 12 years, and a booster dose should be administered at age 16 years. Routine immunization is not recommended for other age groups in the United States, with the exception of people at increased risk for meningococcal disease.